APO RESEARCH · REPORT
Livestock Animal Vaccines
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
Product & engineering
Understand the product.
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
Selected research
Industry Growth & Trends
Global Livestock Animal Vaccines Industry Growth and Trends Forecast to 2032
Market perspective
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
There are three kinds of Livestock Animal Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines and others. Live attenuated vaccines hold the largest share of the Livestock Animal Vaccines market, with a sales market share nearly 53.75% in 2019. Livestock Animal Vaccine is use in Pig, Cattle, Poultry and Other. The most proportion of Livestock Animal Vaccine is used in Cattle, and the market share in 2019 is about 34.73% and the proportion of Pigs in 2019 is about 23.35%. Market competition is intense; Merck, Zoetis, Boehringer Ingelheim, Ceva, etc. are the leader of the industry, and top 5 players hold about 70.27% revenue market share, with high-end customers.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Livestock Animal Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Livestock Animal Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Livestock Animal Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Livestock Animal Vaccines.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Livestock Animal Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Livestock Animal Vaccines Market by Company
Merck
Boehringer Ingelheim
Zoetis
Ceva
Elanco
CAHIC
Jinyu Bio-Technology
HVRI
Ringpu Biology
Yebio
DHN
Kyoto Biken Laboratories
WINSUN
FATRO
CAVAC
MEVAC
Biovac
ChengDu Tecbond
Vaksindo
Bio-Labs
Livestock Animal Vaccines Segment by Type
Live Attenuated Vaccine
Inactivated Vaccine
Other Vaccines
Livestock Animal Vaccines Segment by Application
Pig
Cattle
Poultry
Others
Livestock Animal Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Animal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Animal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Animal Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Livestock Animal Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Livestock Animal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Live Attenuated Vaccine
- Inactivated Vaccine
- Other Vaccines
Applications
- Pig
- Cattle
- Poultry
- Others
Companies covered
- Merck
- Boehringer Ingelheim
- Zoetis
- Ceva
- Elanco
- CAHIC
- Jinyu Bio-Technology
- HVRI
- Ringpu Biology
- Yebio
- DHN
- Kyoto Biken Laboratories
- WINSUN
- FATRO
- CAVAC
- MEVAC
- Biovac
- ChengDu Tecbond
- Vaksindo
- Bio-Labs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Livestock Animal Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Livestock Animal Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.3 Livestock Animal Vaccines Market by Type
- 1.3.1 Live Attenuated Vaccine
- 1.3.2 Inactivated Vaccine
- 1.3.3 Other Vaccines
- 1.4 Global Livestock Animal Vaccines Market Size by Type
- 1.4.1 Global Livestock Animal Vaccines Market Size Overview by Type (2021-2032)
- 1.4.2 Global Livestock Animal Vaccines Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Livestock Animal Vaccines Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Livestock Animal Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Livestock Animal Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Livestock Animal Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Livestock Animal Vaccines Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Livestock Animal Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Livestock Animal Vaccines Industry Trends
- 2.2 Livestock Animal Vaccines Industry Drivers
- 2.3 Livestock Animal Vaccines Industry Opportunities and Challenges
- 2.4 Livestock Animal Vaccines Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Livestock Animal Vaccines Revenue (2021-2026)
- 3.2 Global Top Players by Livestock Animal Vaccines Sales (2021-2026)
- 3.3 Global Top Players by Livestock Animal Vaccines Price (2021-2026)
- 3.4 Global Livestock Animal Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Livestock Animal Vaccines Major Company Production Sites & Headquarters
- 3.6 Global Livestock Animal Vaccines Company, Product Type & Application
- 3.7 Global Livestock Animal Vaccines Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Livestock Animal Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Livestock Animal Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Livestock Animal Vaccines Tier 1, Tier 2, and Tier 3
4 Livestock Animal Vaccines Regional Status and Outlook
- 4.1 Global Livestock Animal Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Livestock Animal Vaccines Historic Market Size by Region
- 4.2.1 Global Livestock Animal Vaccines Sales in Volume by Region (2021-2026)
- 4.2.2 Global Livestock Animal Vaccines Sales in Value by Region (2021-2026)
- 4.2.3 Global Livestock Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Livestock Animal Vaccines Forecasted Market Size by Region
- 4.3.1 Global Livestock Animal Vaccines Sales in Volume by Region (2027-2032)
- 4.3.2 Global Livestock Animal Vaccines Sales in Value by Region (2027-2032)
- 4.3.3 Global Livestock Animal Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Livestock Animal Vaccines by Application
- 5.1 Livestock Animal Vaccines Market by Application
- 5.1.1 Pig
- 5.1.2 Cattle
- 5.1.3 Poultry
- 5.1.4 Others
- 5.2 Global Livestock Animal Vaccines Market Size by Application
- 5.2.1 Global Livestock Animal Vaccines Market Size Overview by Application (2021-2032)
- 5.2.2 Global Livestock Animal Vaccines Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Livestock Animal Vaccines Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Livestock Animal Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Livestock Animal Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Livestock Animal Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Livestock Animal Vaccines Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Livestock Animal Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Merck Livestock Animal Vaccines Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Boehringer Ingelheim
- 6.2.1 Boehringer Ingelheim Company Information
- 6.2.2 Boehringer Ingelheim Business Overview
- 6.2.3 Boehringer Ingelheim Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Boehringer Ingelheim Livestock Animal Vaccines Product Portfolio
- 6.2.5 Boehringer Ingelheim Recent Developments
- 6.3 Zoetis
- 6.3.1 Zoetis Company Information
- 6.3.2 Zoetis Business Overview
- 6.3.3 Zoetis Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Zoetis Livestock Animal Vaccines Product Portfolio
- 6.3.5 Zoetis Recent Developments
- 6.4 Ceva
- 6.4.1 Ceva Company Information
- 6.4.2 Ceva Business Overview
- 6.4.3 Ceva Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Ceva Livestock Animal Vaccines Product Portfolio
- 6.4.5 Ceva Recent Developments
- 6.5 Elanco
- 6.5.1 Elanco Company Information
- 6.5.2 Elanco Business Overview
- 6.5.3 Elanco Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Elanco Livestock Animal Vaccines Product Portfolio
- 6.5.5 Elanco Recent Developments
- 6.6 CAHIC
- 6.6.1 CAHIC Company Information
- 6.6.2 CAHIC Business Overview
- 6.6.3 CAHIC Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 CAHIC Livestock Animal Vaccines Product Portfolio
- 6.6.5 CAHIC Recent Developments
- 6.7 Jinyu Bio-Technology
- 6.7.1 Jinyu Bio-Technology Company Information
- 6.7.2 Jinyu Bio-Technology Business Overview
- 6.7.3 Jinyu Bio-Technology Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Jinyu Bio-Technology Livestock Animal Vaccines Product Portfolio
- 6.7.5 Jinyu Bio-Technology Recent Developments
- 6.8 HVRI
- 6.8.1 HVRI Company Information
- 6.8.2 HVRI Business Overview
- 6.8.3 HVRI Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 HVRI Livestock Animal Vaccines Product Portfolio
- 6.8.5 HVRI Recent Developments
- 6.9 Ringpu Biology
- 6.9.1 Ringpu Biology Company Information
- 6.9.2 Ringpu Biology Business Overview
- 6.9.3 Ringpu Biology Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Ringpu Biology Livestock Animal Vaccines Product Portfolio
- 6.9.5 Ringpu Biology Recent Developments
- 6.10 Yebio
- 6.10.1 Yebio Company Information
- 6.10.2 Yebio Business Overview
- 6.10.3 Yebio Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Yebio Livestock Animal Vaccines Product Portfolio
- 6.10.5 Yebio Recent Developments
- 6.11 DHN
- 6.11.1 DHN Company Information
- 6.11.2 DHN Business Overview
- 6.11.3 DHN Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 DHN Livestock Animal Vaccines Product Portfolio
- 6.11.5 DHN Recent Developments
- 6.12 Kyoto Biken Laboratories
- 6.12.1 Kyoto Biken Laboratories Company Information
- 6.12.2 Kyoto Biken Laboratories Business Overview
- 6.12.3 Kyoto Biken Laboratories Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Kyoto Biken Laboratories Livestock Animal Vaccines Product Portfolio
- 6.12.5 Kyoto Biken Laboratories Recent Developments
- 6.13 WINSUN
- 6.13.1 WINSUN Company Information
- 6.13.2 WINSUN Business Overview
- 6.13.3 WINSUN Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 WINSUN Livestock Animal Vaccines Product Portfolio
- 6.13.5 WINSUN Recent Developments
- 6.14 FATRO
- 6.14.1 FATRO Company Information
- 6.14.2 FATRO Business Overview
- 6.14.3 FATRO Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 FATRO Livestock Animal Vaccines Product Portfolio
- 6.14.5 FATRO Recent Developments
- 6.15 CAVAC
- 6.15.1 CAVAC Company Information
- 6.15.2 CAVAC Business Overview
- 6.15.3 CAVAC Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 CAVAC Livestock Animal Vaccines Product Portfolio
- 6.15.5 CAVAC Recent Developments
- 6.16 MEVAC
- 6.16.1 MEVAC Company Information
- 6.16.2 MEVAC Business Overview
- 6.16.3 MEVAC Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 MEVAC Livestock Animal Vaccines Product Portfolio
- 6.16.5 MEVAC Recent Developments
- 6.17 Biovac
- 6.17.1 Biovac Company Information
- 6.17.2 Biovac Business Overview
- 6.17.3 Biovac Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Biovac Livestock Animal Vaccines Product Portfolio
- 6.17.5 Biovac Recent Developments
- 6.18 ChengDu Tecbond
- 6.18.1 ChengDu Tecbond Company Information
- 6.18.2 ChengDu Tecbond Business Overview
- 6.18.3 ChengDu Tecbond Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 ChengDu Tecbond Livestock Animal Vaccines Product Portfolio
- 6.18.5 ChengDu Tecbond Recent Developments
- 6.19 Vaksindo
- 6.19.1 Vaksindo Company Information
- 6.19.2 Vaksindo Business Overview
- 6.19.3 Vaksindo Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Vaksindo Livestock Animal Vaccines Product Portfolio
- 6.19.5 Vaksindo Recent Developments
- 6.20 Bio-Labs
- 6.20.1 Bio-Labs Company Information
- 6.20.2 Bio-Labs Business Overview
- 6.20.3 Bio-Labs Livestock Animal Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Bio-Labs Livestock Animal Vaccines Product Portfolio
- 6.20.5 Bio-Labs Recent Developments
7 North America by Country
- 7.1 North America Livestock Animal Vaccines Sales by Country
- 7.1.1 North America Livestock Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Livestock Animal Vaccines Sales by Country (2021-2026)
- 7.1.3 North America Livestock Animal Vaccines Sales Forecast by Country (2027-2032)
- 7.2 North America Livestock Animal Vaccines Market Size by Country
- 7.2.1 North America Livestock Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Livestock Animal Vaccines Market Size by Country (2021-2026)
- 7.2.3 North America Livestock Animal Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Livestock Animal Vaccines Sales by Country
- 8.1.1 Europe Livestock Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Livestock Animal Vaccines Sales by Country (2021-2026)
- 8.1.3 Europe Livestock Animal Vaccines Sales Forecast by Country (2027-2032)
- 8.2 Europe Livestock Animal Vaccines Market Size by Country
- 8.2.1 Europe Livestock Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Livestock Animal Vaccines Market Size by Country (2021-2026)
- 8.2.3 Europe Livestock Animal Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Livestock Animal Vaccines Sales by Country
- 9.1.1 Asia-Pacific Livestock Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Livestock Animal Vaccines Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Livestock Animal Vaccines Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Livestock Animal Vaccines Market Size by Country
- 9.2.1 Asia-Pacific Livestock Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Livestock Animal Vaccines Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Livestock Animal Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Livestock Animal Vaccines Sales by Country
- 10.1.1 South America Livestock Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Livestock Animal Vaccines Sales by Country (2021-2026)
- 10.1.3 South America Livestock Animal Vaccines Sales Forecast by Country (2027-2032)
- 10.2 South America Livestock Animal Vaccines Market Size by Country
- 10.2.1 South America Livestock Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Livestock Animal Vaccines Market Size by Country (2021-2026)
- 10.2.3 South America Livestock Animal Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Livestock Animal Vaccines Sales by Country
- 11.1.1 Middle East and Africa Livestock Animal Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Livestock Animal Vaccines Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Livestock Animal Vaccines Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Livestock Animal Vaccines Market Size by Country
- 11.2.1 Middle East and Africa Livestock Animal Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Livestock Animal Vaccines Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Livestock Animal Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Livestock Animal Vaccines Value Chain Analysis
- 12.1.1 Livestock Animal Vaccines Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Livestock Animal Vaccines Production Mode & Process
- 12.2 Livestock Animal Vaccines Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Livestock Animal Vaccines Distributors
- 12.2.3 Livestock Animal Vaccines Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst